2023 Medicare Prescription Drug Pricing 
Health Law Advisor
MARCH 7, 2023
This feedback must be submitted to CMS by March 11, 2023 via email ( IRARebateandNegotiation@cms.hhs.gov ). Stakeholders can view CMS’s issuance of the Initial Inflation Rebate Guidances as an early step in the complex, multi-year process CMS must undertake to implement the various IRA provisions.
Healthcare Law Blog
FEBRUARY 22, 2023
The Rebate Programs are administered as part of the prescription drug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Jane Sarashon
JULY 18, 2024
We’ve discussed the hockey-stick rise in the adoption and persistent use of GLP-1 drugs for managing diabetes and obesity here in Health Populi. This graph diagrams utilization, unit cost, and cost as a percent of overall medical cost trend: note that by the middle of 2023, GLP-1 drug costs for Group health plan members comprised 13.6%
Healthcare It News
APRIL 28, 2022
"With prescription drug prices rising at every turn, patients need price transparency and the ability to discuss options with their doctors during office visits," Davis advised. ADVICE FOR OTHERS.
Jane Sarashon
FEBRUARY 27, 2024
In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.
Health Care Law Brief
JANUARY 19, 2022
On December 31, 2021, New York Governor Kathy Hochul signed landmark legislation to increase the transparency of prescription drug pricing and to establish requirements on pharmacy middlemen. Failure to obtain a license by 2023 could result in a cease and desist order from DFS and financial penalties. 1] [link].
Health Populi
OCTOBER 24, 2022
Add to that scenario a growing consensus for a likely recession in 2023. health care system not seen since the 1968 creation of Medicare, coupled with decreased reimbursement due to health care reform. Consumers will be facing greater medical price inflation in 2023 for health insurance plans, based on the latest forecast from WTW.
Expert insights. Personalized for you.
52 
Let's personalize your content